Improvements in Cardiometabolic Outcomes Seen With Healthy Vegan Diet
By Elana Gotkine HealthDay Reporter
THURSDAY, Nov. 30, 2023 -- Following a healthy vegan diet leads to improvements in cardiometabolic outcomes compared with a healthy omnivorous diet, according to a study published online Nov. 30 in JAMA Network Open.
Matthew J. Landry, Ph.D., from Stanford University in Palo Alto, California, and colleagues compared the effects of a healthy vegan versus healthy omnivorous diet in cardiometabolic measures during an eight-week intervention in a single-center randomized clinical trial involving 22 pairs of twins. Participants were randomly assigned to a vegan or omnivorous diet for eight weeks.
The researchers found that after eight weeks, the twins randomly assigned to the vegan diet had significant mean decreases in low-density lipoprotein cholesterol concentration (−13.9 mg/dL), fasting insulin level (−2.9 µIU/mL), and body weight (−1.9 kg) compared with twins randomly assigned to an omnivorous diet.
"We observed cardiometabolic advantages for the healthy vegan versus the healthy omnivorous diet among healthy, adult identical twins," the authors write. "Clinicians may consider recommending plant-based diets to reduce cardiometabolic risk factors, as well as aligning with environmental benefits."
One author disclosed receiving funding from Beyond Meat.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.